Cosibelimab for CSCC in Patients With Kidney Transplant or Hematologic Malignancy
Dana-Farber Cancer Institute
Dana-Farber Cancer Institute
University of Florida
Pfizer
Jonsson Comprehensive Cancer Center
University of Nebraska
Cancer Research UK
Massive Bio, Inc.
Washington University School of Medicine
Tempus AI
Arbeitsgemeinschaft medikamentoese Tumortherapie